Project description
Empowering medicine with AI and data science
The need for data science, including AI, machine learning and digital health in medical science is rapidly growing as these technologies enable more precise, personalised care. Integrating advanced data analysis techniques with medical research will help optimise clinical decision-making and enhance patient outcomes. With the support of the Marie Skłodowska-Curie Actions programme, the AIPD project aims to create an international, interdisciplinary graduate school to train the next generation of medical data scientists with a strong translational focus. The project will provide students with expertise in ethics and legal frameworks. It will focus on Parkinson’s disease, advance AI models for personalised treatment and diagnosis, and address ethical concerns in AI use.
Objective
In response to the growing need for specialized data scientists in healthcare, our initiative aims to establish an international, interdisciplinary graduate school that educate the next generation of medical data scientists, with a strong translational focus bridging academia and industry. This is strengthened by the active involvement of leading global pharmaceutical and med-tech companies as well as SMEs in the AI field, thus ensuring that our research and training remain at the forefront of industry and healthcare. We propose a comprehensive training program offering PhD students not only a robust foundation in data science, including AI/ML and digital health, but also a deep understanding of ethical, legal and regulatory frameworks, including GDPR, the European Health Data Space and the AI Act. Our curriculum is unique in its integration of entrepreneurial thinking and a focus on Parkinsons disease (PD) as an application field. At the same time, the methodologies and insights gained will have broader applications in various disorders, thus applicable to other areas of healthcare. We will move with our research program clearly beyond the state of the art by:
- Developing new AI/ML models spanning the entire journey of a PD patient to support medical decision-making on a more individual basis,
- Pioneering the use of recent causal AI/ML techniques in PD research,
- Investigating the optimization of future clinical trials,
- Providing novel insights into digital and neuroimaging markers,
- Developing innovative algorithmic solutions to enhance the generalizability of AI/ML models,
- Providing understanding of the ethical, legal and regulatory basis of the use of AI in medical practice.
All participants are highly committed to the research, teaching, supervision and management activities in this program, and this commitment is supported by existing working relationships through other projects, such as ERA PerMed DIGIPD, IHI PREDICTOM and IHI IDERHA.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques.
You need to log in or register to use this function
Programme(s)
- HORIZON.1.2 - Marie Skłodowska-Curie Actions (MSCA) Main Programme
Coordinator
80686 Munchen
Germany